Intragastric balloon as an adjunct to lifestyle programme in severely obese adolescents: Impact on biomedical outcomes, and skeletal health"

SACHDEV, P, REECE, Lindsey, THOMSON, M, NATARAJAN, A, COPELAND, Robert, WALES, J K and WRIGHT, N P (2017). Intragastric balloon as an adjunct to lifestyle programme in severely obese adolescents: Impact on biomedical outcomes, and skeletal health". International journal of obesity (2005), 42 (1), 115-118.

[img]
Preview
PDF
Reece-Intragastric balloon as an adjunct to lifestyle programme(VoR).pdf - Published Version
Creative Commons Attribution Non-commercial No Derivatives.

Download (247kB) | Preview
[img]
Preview
PDF
Reece-Intragastric balloon as an adjunct to lifestyle programme(AM).pdf - Accepted Version
Creative Commons Attribution No Derivatives.

Download (1MB) | Preview
Official URL: http://www.nature.com/ijo/journal/vaop/naam/abs/ij...
Link to published version:: https://doi.org/10.1038/ijo.2017.215
Related URLs:

    Abstract

    Intragastric Balloons are a temporary, reversible, and safer option compared to bariatric surgery to promote significant weight loss leading to improved metabolic outcomes. However due to subsequent weight regain, alternative procedures are now preferred in adults. In adolescents, more amenable to lifestyle change, balloons may be an alternative to less reversible procedures. Our aim was to assess the tolerability and efficacy of the intragastric balloon in severely obese adolescents and the impact of associated weight loss on biomedical outcomes (glucose metabolism, blood pressure, lipid profiles) and bone density. A 2-year cohort study of 12 adolescents (BMI >3.5 s.d., Tanner stage >4) following 6 months intragastric balloon placement was carried out. Subjects underwent anthropometry, oral glucose tolerance test, and DEXA scans at 0, 6 and 24 months. Results showed clinically relevant improvements in blood pressure, insulin: glucose metabolism, liver function and sleep apnoea at 6 months. Changes were not sustained at 2 years though some parameters (Diastolic BP, HBA1c, insulin AUC) demonstrated longer-term improvement despite weight regain. Despite weight loss, bone mass accrual showed age appropriate increases. In conclusion, the intra-gastric balloon was safe, well tolerated and effective in supporting short-term weight loss and clinically relevant improvement in obesity related complications, which resolved in some individuals. Benefits were not sustained in the majority at 2 years.International Journal of Obesity accepted article preview online, 05 September 2017. doi:10.1038/ijo.2017.215.

    Item Type: Article
    Additional Information: ** From PubMed via Jisc Publications Router. ** History: ** received: 30-06-2016 ** revised: 10-05-2017 ** accepted: 25-05-2017
    Research Institute, Centre or Group - Does NOT include content added after October 2018: Centre for Sport and Exercise Science
    Identification Number: https://doi.org/10.1038/ijo.2017.215
    Page Range: 115-118
    SWORD Depositor: Jill Hazard
    Depositing User: Jill Hazard
    Date Deposited: 19 Sep 2017 16:11
    Last Modified: 17 Mar 2021 15:01
    URI: http://shura.shu.ac.uk/id/eprint/16769

    Actions (login required)

    View Item View Item

    Downloads

    Downloads per month over past year

    View more statistics